Patent · US Active

Pyrimidine compounds and their use as gamma secretase modulators

US9439904B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

Acturum Life Science AB · SE

Inventors

Yevgeni Besidski · Tumba, SE
Ulrika Yngve · Malung, SE
Kim Paulsen · Malung, SE
Christian Erik Linde · Stockholm, SE
Istvan Macsari · Gately Drive, SE
Jonas Malmborg · Linköping, SE
Alexander Paptchikhine · Uppsala, SE
Per I Arvidsson · Haditha, IQ

Key dates

Filing date	Jun 3, 2014
Grant date	Sep 13, 2016
Priority date	—
Expiry date	Jun 3, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The invention also relates to pharmaceutical compositions comprising these compounds, to processes for making these compounds, and to their use as medicaments for treatment and/or prevention of Aβ-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.